Autonomix Medical, Inc. (AMIX)
2.845
-0.08
(-2.90%)
USD |
NASDAQ |
Oct 16, 16:00
2.845
0.00 (0.00%)
After-Hours: 16:58
Autonomix Medical Enterprise Value : -1.871M for Oct. 15, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 15, 2026 | -1.871M |
| October 14, 2026 | -1.887M |
| October 13, 2026 | -1.828M |
| October 12, 2026 | -1.779M |
| October 09, 2026 | -1.773M |
| October 08, 2026 | -1.763M |
| October 07, 2026 | -1.611M |
| October 06, 2026 | -1.578M |
| October 05, 2026 | -1.540M |
| October 02, 2026 | -1.410M |
| October 01, 2026 | -1.334M |
| September 30, 2026 | -1.383M |
| September 29, 2026 | -1.426M |
| September 28, 2026 | -1.383M |
| September 25, 2026 | -1.28M |
| September 24, 2026 | -1.253M |
| September 23, 2026 | -1.302M |
| September 22, 2026 | -1.220M |
| September 21, 2026 | -1.264M |
| September 18, 2026 | -1.177M |
| September 17, 2026 | -1.139M |
| September 16, 2026 | -1.226M |
| September 15, 2026 | -1.177M |
| September 14, 2026 | -1.112M |
| September 11, 2026 | -1.090M |
| Date | Value |
|---|---|
| September 10, 2026 | -1.082M |
| September 09, 2026 | -0.9817M |
| September 08, 2026 | -0.9763M |
| September 04, 2026 | -0.9708M |
| September 03, 2026 | -0.922M |
| September 02, 2026 | -1.020M |
| September 01, 2026 | -0.8895M |
| August 31, 2026 | -0.8407M |
| August 28, 2026 | -0.575M |
| August 27, 2026 | -0.4069M |
| August 26, 2026 | -0.0001M |
| August 25, 2026 | 0.4391M |
| August 24, 2026 | -0.5478M |
| August 21, 2026 | -0.6021M |
| August 20, 2026 | -0.6021M |
| August 19, 2026 | -0.255M |
| August 18, 2026 | -0.114M |
| August 17, 2026 | 0.0107M |
| August 14, 2026 | 0.2548M |
| August 13, 2026 | 0.2602M |
| August 12, 2026 | 0.6262M |
| August 11, 2026 | 1.486M |
| August 10, 2026 | 1.578M |
| August 07, 2026 | 1.985M |
| August 06, 2026 | 3.140M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 208.79B |
| AngioDynamics, Inc. | 468.04M |
| Alphatec Holdings, Inc. | 2.178B |
| AtriCure, Inc. | 2.845B |
| Baxter International, Inc. | 20.00B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.728M |
| Total Expenses (Quarterly) | 2.728M |
| EPS Diluted (Quarterly) | -5.018 |
| Earnings Yield | -1.63K% |
| Normalized Earnings Yield | -1633.91 |